Our strategy Our current strategic period started in 2021, setting out our vision and goals to achieve testing for healthy and safe lives.
G20 engagement We are highlighting the importance of diagnostics in ensuring that the G20 health priorities are achieved.
Commitment tracker An open platform for the global health community to share and track commitments that will support Member States in implementing the WHA Resolution on diagnostics.
100 Days Mission A plan for the world to be able to respond to and extinguish the global threat of the next Disease X within 100 days of WHO declaring a major outbreak or pandemic.
TESTED An exhibition about medical diagnosis, and why it matters that half the world has no access to testing.
Diagnostics & disease elimination Elimination of a disease as a public health problem refers to the reduction of the incidence or prevalence of a particular disease.
FIND Board Chair Dr Ayoade Alakija Appointed Ministerial Global Envoy for Antimicrobial Resistance Government of Nigeria appoints FIND Board Chair Dr Ayoade Alakija as Ministerial Global Envoy on AMR. Dr Alakija will lead strategic engagement and international mobilisation to address AMR.
DxConnect test directory Searchable directory of diagnostic tests for various diseases under the DxConnect umbrella.
Data for decisions Diagnostics provide critical information for healthcare professionals, decision-makers, and people living with diseases and health conditions.
The diagnostic journey From R&D to implementation, the diagnostic value chain can be thought of as a journey of interconnected steps, or a "virtuous cycle".
WHA Resolution on strengthening diagnostics capacity The Lancet Commission on diagnostics was published in 2021, putting forward recommendations to accelerate and transform access to diagnostics globally.
Scientific articles WHO target product profile for TB detection at peripheral settings: 2024 update Mikashmi Kohli et al 11 June 2025
Scientific articles Challenges in Hb A1c Point-of-Care Testing: Only 6 of 19 Hb A1c Point-of-Care Devices Meet IFCC and NGSP Certification Criteria on Independent Evaluation Clinical Chemistry, Erna Lenters-Westra, et al 26 May 2025
Scientific articles Modeling the impact and cost of a culture-dependent molecular test for antimicrobial resistance in resource-limited settings Clinical Infectious Diseases, Joshua M Chevalier, et al 12 May 2025
Scientific articles Evaluation of the diagnostic accuracy of the ReLASV Pan-Lassa Antigen Rapid Test for Lassa Fever in Nigeria PLOS Global Public Health, Hanesh F. Chi, et al. 21 April 2025
Scientific articles Performance of 2 Finger-Stick Blood Tests to Triage Adults With Symptoms of Pulmonary Tuberculosis: A Prospective Multisite Diagnostic Accuracy Study Clinical Infectious Diseases, Jayne S Sutherland, et al. 16 April 2025
Scientific articles Rapid bacterial identification and resistance detection using a low complexity molecular diagnostic platform in Zimbabwe PLOS Global Public Health, Tinashe Mwaturura, et al 9 April 2025
Scientific articles Leveraging a digital network of pharmacy professionals to test a technology-assisted model to improve pharmacy access to quality-assured COVID-19 rapid antigen tests approved for self-use in Vietnam PLoS ONE, Tien Ho, et al. 19 March 2025
Scientific articles Multivariable regression models improve accuracy and sensitive grading of antibiotic resistance mutations in Mycobacterium tuberculosis Nature Communications, Sanjana G. Kulkarni, et al. 4 March 2025
Scientific articles Availability, prices and affordability of self-monitoring blood glucose devices: surveys in six low-income and middle-income countries BMJ Public Health, Margaret Ewen, et al. 22 February 2025
Scientific articles Evaluation of a novel point-of-care lateral flow assay screening for Neisseria gonorrhoeae infection among pregnant women in Zimbabwe PLOS Global Public Health, Kevin Martin, et al. 11 February 2025
